RWTH : Histopathological Biomarkers for Nanomedicine-Enhanced Cancer Therapy
Scientists from RWTH’s Institute for Experimental Molecular Imaging have now published their findings on the identification of suitable tumor patients for nanoparticle-based cancer therapies in clinical trials.
Nanomedical formulations…